FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
We have now added a new section called the "Assay History List" to the "At A Gla...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...